Biocon signs MoU with Deakin University

New Delhi, June 7 (UNI) Pharma company Biocon Ltd today signed a Memorandum of Understanding (MoU) with Australia's Deakin University to establish the Deakin Research Institute at Bangaluru and develop a mammalian cell bio-processing facility at Geelong, Australia.

The University will also, through its Metabolic Research Unit, undertake research in the areas of metabolic diseases on behalf of Biocon, said a statement.

''This partnership will provide valuable access to a world of medical knowledge and scientific training, together with opportunities for exchange of scientists to facilitate projects in areas of mutual interest,'' said Biocon Chairperson and Managing Director Kiran Mazumdar Shaw.

UNI